Researchers identified a unique protein signature in the blood of BMD and LGMD patients that may reflect disease progression.

After a busy year, columnist Betty Vertin is grateful that her three sons with DMD always have one another for socializing.

Ifetroban improved heart function and reduced cardiac damage biomarkers in people with DMD in a Phase 2 clinical trial.

The FDA has granted rare pediatric disease designation to PBGENE-DMD, an experimental gene-editing therapy for Duchenne ...

The U.S. Food and Drug Administration is due to review data on deramiocel, a cell therapy up for approval for heart disease ...

A recent dream leaves columnist Robin Stemple questioning how his disability progression due to FSHD affects his family and ...

Doctors can use several tests to diagnose muscular dystrophy (MD). A correct diagnosis gives patients an understanding of how their disease is likely to progress. It also helps doctors do a better job ...

Summer can be rough for folks with muscular dystrophy, columnist Patrick Moeschen writes, but it can also bring adventures in appreciation.

Bethlem myopathy is a milder form of congenital muscular dystrophy caused by mutations in the COL6A1, COL6A2, or COL6A3 genes, which encode for components of a protein called collagen type 6. Bethlem ...

Understanding how corticosteroids work, when they’re typically started, and how their side effects are managed can help people living with DMD and their caregivers make informed decisions about taking ...

Living with muscular dystrophy can be challenging, and there are considerations that must be taken into account on a day-to-basis and in certain situations to help patients manage the disease. Many ...